Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Dienogest, a synthetic steroid with progestational activity, is used as a component of oral contraceptives and is currently being evaluated clinically for the treatment of endometriosis. The present study was conducted to confirm the effects of dienogest on experimental endometriosis in rats and to elucidate its mechanism of action. DESIGN: Experimental endometriosis induced by autotransplantation of endometrium in rats. METHODS: Endometrial implants, immune system, and bone mineral were investigated after 3 weeks of medication. RESULTS: Dienogest (0.1-1 mg/kg per day, p.o.) reduced the endometrial implant volume to the same extent as danazol (100 mg/kg per day, p.o.). Simultaneously, dienogest ameliorated the endometrial implant-induced alterations of the immune system: i.e. it increased the natural killer activity of peritoneal fluid cells and splenic cells, decreased the number of peritoneal fluid cells, and decreased interleukin-1beta production by peritoneal macrophages. In contrast, danazol (100 mg/kg per day, p.o.) and buserelin (30 microg/kg per day, s.c.) had none of these immunologic effects. Additionally, combined administration of dienogest (0.1 mg/kg per day) plus buserelin (0.3 microg/kg per day) suppressed the bone mineral loss induced by buserelin alone, with no reduction of the effect on endometrial implants. In vitro studies on dienogest revealed an antiproliferative effect on rat endometrial cells due to inhibition of protein kinase C activity plus a partial progestational effect. CONCLUSIONS: Dienogest appears to be a potent agent with mechanisms of action different from those of danazol and GnRH agonists currently available for the treatment of endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some studies suggest that progestins can normalize peritoneal fluid characteristics, which may decrease factors that enhance sensitization and pain.”
From Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications (2011) · cites this paper as Katsuki et al., 1998
In the citing paper
“In vivo, dienogest decreases peritoneal fluid macrophage IL-1b production and angiogenesis, normalizes peritoneal fluid cell number and increases peritoneal fluid cells natural killer activity”
From Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications (2011) · cites this paper as Katsuki et al., 1998
In the citing paper
“Dienogest and other progestins have a number of putative mechanisms of action in endometriosis, including reduced growth, proliferation and neoangiogenesis of lesions [20, 21] as well as an antiinflammatory effect [22].”
From Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment (2012) · cites this paper as [20]
Citations
Cites
Consensus development conference: prophylaxis and treatment of osteoporosis.
(1987) · BMJ · doi:10.1136/bmj.295.6603.914 · Cited by 727
Studies on the surgical induction of endometriosis in the rat.
Vernon, M. W., & Wilson, E. A. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48988-0 · Cited by 482
Oosterlynck, D. J., Cornillie, F. J., Waer, M., Vandeputte, M., & Koninckx, P. R. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54414-8 · Cited by 441
Continuous monitoring of ATP-converting reactions by purified firefly luciferase
Lundin, A., Rickardsson, A., & Thore, A. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90116-0 · Cited by 307
Halme, J., Becker, S., & Haskill, S. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90333-4 · Cited by 286
Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery
Eisermann, J., Gast, M. J., Pineda, J., Odem, R. R., & Collins, J. L. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60185-1 · Cited by 280
The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis
Oosterlynck, D. J., Meuleman, C., Waer, M., Vandeputte, M., & Koninckx, P. R. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55224-8 · Cited by 242
Taketani, Y., Kuo, T.-M., & Mizuno, M. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91672-x · Cited by 241
Danazol: Endocrine pharmacology and therapeutic applications
Barbieri, R. L., & Ryan, K. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90611-6 · Cited by 208
Lanthanides as probes for time-resolved fluorometric immunoassays
Hemmilä, I. A. (1988) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518809085747 · Cited by 146
Cited by
Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications
Stratton, P., & Berkley, K. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq050 · Cited by 442
Animal models in endometriosis research
Grümmer, R. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml026 · Cited by 214
Casper, R. F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.003 · Cited by 205
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Osuga, Y., Koga, K., Hirota, Y., Hirata, T., Yoshino, O., & Taketani, Y. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00887.x · Cited by 190
Metadata
- Authors
- Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S.
- Affiliations
- Mochida Pharmaceutical (Japan) (JP)
- Keio University (JP)
- Corresponding author
- Katsuki, Y
- ORCID
- Udagawa, Y
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02-01
- Volume
- 138
- Issue
- 2
- Pages
- 216-226
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2115466905
- Cited by
- 84
- References
- 33
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- dienogest, endometriosis, progestin therapy, endometriotic implants, danazol, buserelin, GnRH agonist, natural killer cells, IL-1β, peritoneal macrophages, bone mineral loss, protein kinase C, endometrial proliferation, immunomodulation
- MeSH terms
- Cyclic AMP, Animals, Buserelin, Cell Division, Cytotoxicity, Immunologic, Danazol, Disease Models, Animal, Endometriosis, Enzyme Inhibitors, Estradiol, Female, Immunity, Cellular, Interleukin-1, Killer Cells, Natural, Nandrolone, Progesterone, Protein Kinase C, Rats, Sprague-Dawley, Macrophages, Peritoneal, Cyclic AMP-Dependent Protein Kinases, Progesterone Congeners, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. https://app.cochat.ai/papers/10.1530/eje.0.1380216
- The paper
- Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S. (1998). Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.1380216
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.